Navigation Links
Luminex Corporation Reports Third Quarter 2011 Results
Date:11/1/2011

6813,743223%FINANCIAL OUTLOOK AND GUIDANCE The Company reaffirms its 2011 annual revenue guidance of $180 million to $185 million, or an increase of between 27 to 31 percent over reported 2010 annual revenue.

CONFERENCE CALL Management will host a conference call to discuss the operating highlights and financial results for the third quarter ended September 30, 2011, on Tuesday, November 1, 2011, at 4:00 p.m. Central time/ 5:00 p.m. Eastern time.  The conference call will be webcast live and will be accompanied by a slide presentation, both of which may be accessed at Luminex Corporation's website at http://www.luminexcorp.com.  Simply log on to the web at the address above, go to the Company section and access the Investor Relations link.  Please go to the website at least 15 minutes prior to the call to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the call and slides will be archived for six months on the website using the 'replay' link.

Luminex develops, manufactures and markets proprietary biological testing technologies with applications throughout the life sciences industry.  The Company's xMAP® system is an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics research markets.  The Company's xMAP technology is sold worldwide and is in use in leading research laboratories as well as major pharmaceutical, diagnostic and biotechnology companies.  Further information on Luminex or xMAP can be obtained on the Internet at

SOURCE Luminex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Luminex Corporation Receives Deloitte Technology Fast 500™ Award
2. Luminex Corporation Third Quarter Earnings Release Scheduled for November 1, 2011
3. Luminex Corporation Hosts Ninth Annual Planet xMAP Europe in Vienna
4. Luminex Corporation to Present at Upcoming Investment Conferences In September
5. Luminex Corporation Reports Second Quarter 2011 Results
6. Luminex Corporation Receives U.S. FDA Clearance for New, Front Line Respiratory Viral Panel Test
7. Luminex Corporation Second Quarter Earnings Release Scheduled for August 8, 2011
8. Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc.
9. Luminex Corporation Named Most Innovative Company of the Year and Receives Business Innovation of the Year Award for MAGPIX® System
10. Luminex Corporation Announces Agreement to Acquire EraGen Biosciences, Inc.
11. Luminex and Life Technologies Sign Agreement for Global Distribution of the Award-Winning MAGPIX® Multiplexing Instrument
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... , June 3, 2015  Lightlake Therapeutics ... addiction treatments based on its expertise in opioid ... Lightlake,s partner for treating opioid overdose with intranasal ... New Drug Application (NDA) to the United States ... spray formulation of naloxone, a drug intended to ...
(Date:6/3/2015)... 3, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... license agreement with AbbVie (NYSE: ABBV ) to ... with Halozyme,s ENHANZE ™ platform. ... will receive an initial $23 million payment, followed ... each of up to nine collaboration targets. These ...
(Date:6/3/2015)... 2015  VA North Texas Health Care System ... vBloc, a technology-based, scientifically advanced weight loss therapy.  ... called the Maestro® Rechargeable System that intermittently blocks ... involving food intake and processing between the brain ... customizable to meet the needs of a patient,s ...
Breaking Medicine Technology:Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 2Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 3Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 2Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 3VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 2VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 3
(Date:6/3/2015)... (PRWEB) June 03, 2015 The Canton ... transforms businesses with technology, announced today that Tim Dodge ... Mr. Dodge joins The Canton Group as ... of successful customer engagements. , Tim is a tech ... for a variety of technology companies. Before joining The ...
(Date:6/3/2015)... Seattle, WA (PRWEB) June 03, 2015 On ... for the majority of genetic drug sensitivity (pharmacogenetic) testing that ... expected to impact as many as 19 million of the ... special risk of costly and life-threatening adverse drug events.(1) Sadly, ... save Medicare millions. , Precision Medicine, the use of an ...
(Date:6/3/2015)... June 03, 2015 Horizon Blue Cross Blue ... Magazine as one of the nation’s top employers for diverse ... 6 among its national list of Best Places for Diverse ... the No. 1 Regional Company. This is the sixth ... MBA Magazine for its diverse workplace policies and programs. , ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 A group ... be honored with a Global Inspire Award at DIA’s ... the organization’s outstanding volunteers for their leadership, level of ... , The recipients of the Author(s) of ... of authors whose article has made a significant impact ...
(Date:6/3/2015)... Visual BI Solutions, a leader in ... launch of the second release of its successful ... Studio. The Design Studio EXtension suite allows customers ... into their dashboarding projects. , With the second ... adding key components for customers that are looking ...
Breaking Medicine News(10 mins):Health News:The Canton Group Appoints Tim Dodge as Chief Marketing Officer 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 3Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 5Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 6Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 7Health News:Horizon Blue Cross Blue Shield of New Jersey Named a 2015 Best Place for Diverse Managers and Women to Work by Diversity MBA Magazine 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 4Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 3
... Wednesday evening swayed to the tunes of catchy Bollywood ... awareness// that saw participation of over 10,000 sex workers ... a pair of black trousers, matching shirt and a ... Jalaile" to the delight of the mixed gathering of ...
... with gonorrhea is probably twice as likely to develop bladder ... results in the British Journal of Cancer, lead author David ... the statement based on case studies of around 51,000 American ... men suffering from gonorrhea. Results analyzed showed that ...
... the general public. This was revealed by a research conducted ... ,Among other reasons cited, drug overdose is said to ... ailments, homicides, suicides, cancer, and smoking. This study was conducted ... a researcher and an assistant professor at University of Colorado ...
... grown soy beans may prove to be successful in ... Tulane //University cancer researcher Matthew Burow. ,Burow ... ovarian and breast cancer tumors that are stimulated by ... growth of the tumors by interfering with the tumor’s ...
... emergency medical system in the national capital to help ... and thus reduce fatalities. ,"In collaboration with the ... system in Pune. Delhi will soon have the facility," ... of Indian Origin (AAPI), said Wednesday. ,Under this ...
... acclaimed as the "gold-standard" amongst researchers for scientific studies. ... on the other, has also questioned the worth of ... complementary and alternative medicine (CAM) practices. Majority of CAM ... cure. , ,The question arises as to whether ...
Cached Medicine News:Health News:Gere Jives To Bollywood Songs To Spread AIDS Awareness 2Health News:Indo-American Doctors to Build Emergency Medical System 2Health News:Is Evidence-based Medicine Enough to Support Additional Research in Alternative Medicine? 2
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
With the Symphony family of Pacemakers, Ela presents the most advanced technology on the market. Symphony, lighter than a passport, will take your patients further, offering fast follow-up, using new...
Medicine Products: